dr peter attia semaglutide 246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent 184 - [AMA #29 Sneak

Cardiovascular safety DPP-4 inhibitors provide no benefits above the standard of care for people with established or high risk of atherosclerotic cardiovascular disease, heart failure or chronic kidney disease

In some trials, up to 2540% of total weight lost was lean mass, not fat

FREQUENTLY ASK QUESTIONS: 1

These can include mild reactions such as temporary discomfort at the injection site or minor sensitivity during the infusion process

Wellbutrin (bupropion) [package insert]

This weight-loss pill is attracting new patients, with roughly 80% of prescriptions issued to those who had never taken GLP-1s before, according to management